Showing results (731-740 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|February 4, 2022
Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors?Rodrigo Gutierrez-Quintana, David J Walker, Kaye J Williams, et al.
Neuro-Oncology Advances|February 4, 2022
A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell linesAshish H Shah, Robert Suter, Pavan Gudoor, et al.
Neuro-Oncology Advances|February 21, 2022
Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formationAmanda de Andrade Costa, Jit Chatterjee, Olivia Cobb, et al.
Neuro-Oncology Advances|July 27, 2022
Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumorsKutluay Uluc, Prakash Ambady, Matthew K McIntyre, et al.
Neuro-Oncology Advances|January 31, 2022
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Neuro-Oncology Advances|February 14, 2022
Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot studyNir Peled, Waleed Kian, Edna Inbar, et al.
Neuro-Oncology Advances|October 27, 2021
Multimodal therapy of cavernous sinus meningioma: Impact of surgery and 68Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcomeIndrawati Hadi, Annamaria Biczok, Nicole Terpolilli, et al.
Neuro-Oncology Advances|October 27, 2021
ELTD1 as a multi-focal target for malignant gliomas: preclinical studiesMichelle Zalles, Nataliya Smith, Debra Saunders, et al.
Neuro-Oncology Advances|October 25, 2021
Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastomaShiao-Pei Weathers, Julie Rood-Breithaupt, John de Groot, et al.
Neuro-Oncology Advances|October 1, 2021
Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumorsJoshua N Baugh, Gerrit H Gielen, Dannis G van Vuurden, et al.
Pageof 138